Tomas J. Heyman

Heyman retired as president of JJDC, Johnson & Johnson’s corporate venture capital group in 2019. He spent his entire career at J&J, and led business development for their pharmaceutical group, Janssen, for over 20 years. He was also managing director of Janssen Pharmaceutica, Belgium, their largest subsidiary outside the U.S.

  • October 2023

Added to: Venatorx Pharmaceuticals - Malvern, PA

Venatorx is a late-stage clinical pharmaceutical company focused on improving health outcomes for patients with multidrug-resistant bacterial infections.